The Effect of Coasting on Intracytoplasmic Sperm Injection Outcome in Antagonist and Agonist Cycle
- PMID: 28367298
- PMCID: PMC5215705
- DOI: 10.22074/ijfs.2016.5144
The Effect of Coasting on Intracytoplasmic Sperm Injection Outcome in Antagonist and Agonist Cycle
Abstract
Background: Coasting can reduce the ovarian hyperstimulation syndrome (OHSS) risk in ovulation induction cycles before intracytoplasmic sperm injection (ICSI). This study aimed to investigate the effect of gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist protocols to controlled ovarian hyperstimulation (COH) cycles with coasting on the parameters of ICSI cycles and the outcome.
Materials and methods: In a retrospective cohort study, 117 ICSI cycles were per- formed and coasting was applied due to hyperresponse, between 2006 and 2011. The ICSI outcomes after coasting were then compared between the GnRH agonist group (n=91) and the GnRH antagonist group (n=26).
Results: The duration of induction and the total consumption of gonadotropins were found to be similar. Estradiol (E2) levels on human chorionic gonadotropin (hCG) day were found higher in the agonist group. Coasting days were similar when the two groups were compared. The number of mature oocytes and the fertilization rates were similar in both groups; however, the number of grade 1 (G1) embryos and the number of transferred embryos were higher in the agonist group. Implantation rates were significantly higher in the antagonist group compared to the agonist group. Pregnancy rates/embryo transfer rates were higher in the antagonist group; however, this difference was not statistically significant (32.8% for agonist group vs. 39.1% for antagonist group, P>0.05).
Conclusion: The present study showed that applying GnRH-agonist and GnRH-antago- nist protocols to coasted cycles did not result in any differences in cycle parameters and clinical pregnancy rates.
Keywords: GnRH Agonist; GnRH Antagonist; Ovarian Hyperstimulation Syndrome.
Similar articles
-
In vitro fertilization cycle outcome after coasting in gonadotropin-releasing hormone (GnRH) agonist versus GnRH antagonist protocols.Fertil Steril. 2009 Feb;91(2):377-82. doi: 10.1016/j.fertnstert.2007.11.086. Epub 2008 Mar 5. Fertil Steril. 2009. PMID: 18321490
-
Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.Hum Reprod. 2016 Jun;31(6):1253-64. doi: 10.1093/humrep/dew051. Epub 2016 Apr 8. Hum Reprod. 2016. PMID: 27060174 Clinical Trial.
-
The prevention of ovarian hyperstimulation syndrome.J Obstet Gynaecol Can. 2014 Nov;36(11):1024-1033. doi: 10.1016/S1701-2163(15)30417-5. J Obstet Gynaecol Can. 2014. PMID: 25574681 Review. English, French.
-
Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.Fertil Steril. 2008 Dec;90(6):2172-8. doi: 10.1016/j.fertnstert.2007.10.033. Epub 2008 Apr 25. Fertil Steril. 2008. PMID: 18439601
-
Premature Progesterone Elevation Does Not Affect Pregnancy Outcome in High-Responder Patients Undergoing Short-Interval Coasting in IVF Cycles.Med Sci Monit Basic Res. 2015 Nov 30;21:247-52. doi: 10.12659/MSMBR.896244. Med Sci Monit Basic Res. 2015. PMID: 26634938 Free PMC article.
Cited by
-
Follicular aspiration versus coasting for ovarian hyper-stimulation syndrome prevention.Saudi Med J. 2018 Mar;39(3):290-295. doi: 10.15537/smj.2018.3.22331. Saudi Med J. 2018. PMID: 29543308 Free PMC article. Clinical Trial.
-
Risk factors, management, and future fertility of empty follicle syndrome: a retrospective study with real-world data.Front Endocrinol (Lausanne). 2024 Jul 11;15:1424837. doi: 10.3389/fendo.2024.1424837. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39055059 Free PMC article.
References
-
- Humaidan P, Quartarolo J, Papanikolaou EG. Preventing ovarian hyperstimulation syndrome: guidance for the clinician. Fertil Steril. 2010;94(2):389–400. - PubMed
-
- Abdallah R, Kligman I, Davis O, Rosenwaks Z. Withholding gonadotropins until human chorionic gonadotropin administration. Semin Reprod Med. 2010;28(6):486–492. - PubMed
-
- Aboulghar MA, Mansour RT. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Hum Reprod Update. 2003;9(3):275–289. - PubMed
-
- Delvigne A, Rozenberg S. A qualitative systematic review of coasting, a procedure to avoid ovarian hyperstimulation syndrome in IVF patients. Hum Reprod Update. 2002;8(3):291–296. - PubMed
LinkOut - more resources
Full Text Sources